Human papillomavirus prevalence is high in oral samples of patients with tonsillar and base of tongue cancer

被引:56
作者
Nordfors, Cecilia [1 ]
Vlastos, Andrea [1 ,2 ]
Du, Juan [1 ]
Ahrlund-Richter, Andreas [1 ,3 ]
Tertipis, Nikolaos [1 ]
Grun, Nathalie [1 ]
Romanitan, Mircea [1 ,4 ]
Haeggblom, Linnea [1 ]
Roosaar, Ann [3 ]
Dahllof, Goran [3 ]
Dona, Maria Gabriella [5 ]
Benevolo, Maria [6 ]
Ramqvist, Torbjorn [1 ]
Munck-Wikland, Eva [2 ]
Dalianis, Tina [1 ]
机构
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, CLINTEC, Dept Otorhinolaryngol Head & Neck Surg, S-17176 Stockholm, Sweden
[3] Karolinska Inst, Dept Dent Med, Stockholm, Sweden
[4] Karolinska Univ Hosp, Karolinska Inst, Dept Audiol & Neurotol CLINTEC, S-17176 Stockholm, Sweden
[5] Inst Dermatol, STI Unit, Rome, Italy
[6] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy
基金
英国医学研究理事会;
关键词
Human papillomavirus (HPV); Oral HPV infection; Mouthwash samples; tonsillar swabs; Oropharyngeal squamous cell carcinoma; Tonsillar cancer base of tongue cancer; HPV INFECTION; EPIDEMIC; RISK; CARCINOMA; WOMEN; DNA;
D O I
10.1016/j.oraloncology.2014.02.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Material and methods: Presence of HPV DNA was analyzed in mouthwash and tonsillar swab samples, if indicative of HPV-positive tonsillar or base of tongue cancer in 76 patients, with suspected head neck cancer, undergoing diagnostic endoscopy at Karolinska University Hospital. The diagnosis and tumor HPV status was later obtained from patients' records. As controls, 37 tumor-free dental visitors were included. Results: Of the 76 patients, 22/29 (76%) and 16/18 (89%) had an HPV-positive tonsillar and base of tongue cancer respectively, with 18/22 (82%) and 8/16 (50%) respectively having tumor concordant HPV-type positive oral samples. Two other HPV-positive oral samples in the base of tongue cancer group did not correlate to the tumor HPV status. Among the remaining patients, 19 with other head neck cancer and 10 with benign conditions, 4/29 (14%) had HPV-positive oral samples. Consequently, of the HPV-positive oral samples, dominated by HPV16 and high signals, 27/32 (84%) were derived from 26 patients with concordant HPV-type positive tonsillar or base of tongue cancer and one patient with an unknown primary head and neck cancer. The other five HPV-positive oral samples, with mainly low signals were derived from two patients with non-concordant HPV-type positive tumor biopsies, two patients with HPV-negative tumor biopsies and a patient with a benign condition. Of the dental patients, 3/37 (8%) had HPV-positive tonsillar swabs with weak signals. Conclusion: In patients with suspected head neck cancer, HPV-positive oral samples, especially HPV16 with high signals, could be indicative of HPV-positive tonsillar or base of tongue cancer. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:491 / 497
页数:7
相关论文
共 28 条
  • [1] Survival in patients with human papillomavirus positive tonsillar cancer in relation to treatment
    Attner, Per
    Nasman, Anders
    Du, Juan
    Hammarstedt, Lalle
    Ramqvist, Torbjorn
    Lindholm, Johan
    Munck-Wikland, Eva
    Dalianis, Tina
    Marklund, Linda
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (05) : 1124 - 1130
  • [2] The role of human papillomavirus in the increased incidence of base of tongue cancer
    Attner, Per
    Du, Juan
    Nasman, Anders
    Hammarstedt, Lalle
    Ramqvist, Torbjorn
    Lindholm, Johan
    Marklund, Linda
    Dalianis, Tina
    Munck-Wikland, Eva
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (12) : 2879 - 2884
  • [3] Blomberg M, 2001, INT J CANCER, V129, P733
  • [4] Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population
    Cañadas, MP
    Bosch, FX
    Junquera, ML
    Ejarque, M
    Font, R
    Ordoñez, E
    de Sanjosé, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (03) : 1330 - 1332
  • [5] Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
    Chaturvedi, Anil K.
    Engels, Eric A.
    Pfeiffer, Ruth M.
    Hernandez, Brenda Y.
    Xiao, Weihong
    Kim, Esther
    Jiang, Bo
    Goodman, Marc T.
    Sibug-Saber, Maria
    Cozen, Wendy
    Liu, Lihua
    Lynch, Charles F.
    Wentzensen, Nicolas
    Jordan, Richard C.
    Altekruse, Sean
    Anderson, William F.
    Rosenberg, Philip S.
    Gillison, Maura L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) : 4294 - 4301
  • [6] Six-month natural history of oral versus cervical human papillomavirus infection
    D'Souza, Gypsyamber
    Fakhry, Carole
    Sugar, Elizabeth A.
    Seaberg, Eric C.
    Weber, Kathleen
    Minkoff, Howard L.
    Anastos, Kathryn
    Palefsky, Joel M.
    Gillison, Maura L.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (01) : 143 - 150
  • [7] Case-control study of human papillomavirus and oropharyngeal cancer
    D'Souza, Gypsyamber
    Kreimer, Aimee R.
    Viscidi, Raphael
    Pawlita, Michael
    Fakhry, Carole
    Koch, Wayne M.
    Westra, William H.
    Gillison, Maura L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) : 1944 - 1956
  • [8] Prevalence of Oral Human Papillomavirus Infection among Youth, Sweden
    Du, Juan
    Nordfors, Cecilia
    Ahrlund-Richter, Andreas
    Sobkowiak, Michal
    Romanitan, Mircea
    Nasman, Anders
    Andersson, Soren
    Ramqvist, Torbjorn
    Dalianis, Tina
    [J]. EMERGING INFECTIOUS DISEASES, 2012, 18 (09) : 1468 - 1471
  • [9] Associations between Oral HPV16 Infection and Cytopathology: Evaluation of an Oropharyngeal "Pap-Test Equivalent" in High-Risk Populations
    Fakhry, Carole
    Rosenthal, Barbara T.
    Clark, Douglas P.
    Gillison, Maura L.
    [J]. CANCER PREVENTION RESEARCH, 2011, 4 (09) : 1378 - 1384
  • [10] Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
    Gillison, ML
    Koch, WM
    Capone, RB
    Spafford, M
    Westra, WH
    Wu, L
    Zahurak, ML
    Daniel, RW
    Viglione, M
    Symer, DE
    Shah, KV
    Sidransky, D
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (09): : 709 - 720